A number of pharmaceutical companies predict the need for booster shots against the Wuhan coronavirus (COVID-19). The push for these booster shots comes amid the spread of the more infectious B16172 delta variant, which is responsible for many breakthrough COVID-19 cases. However, booster shots appear to be another plan for vaccine makers to boost profits. Pfizer and … Continue reading Coronavirus booster shots: Boosting immunity or profits?
Dr. Eddy Bettermann MD 